Table 1. Patient Characteristics.
Patient Demographics |
Brachytherapy (n=448)a | EBRT (n=281)b | P Valuec | |
---|---|---|---|---|
| ||||
No.(%) | No.(%) | |||
Age | <65 | 188 (42.0) | 86 (30.6) | 0.002 |
≥65 | 260 (58.0) | 195 (69.4) | ||
| ||||
PreTX PSA | <4 | 93 (20.8) | 43 (15.3) | 0.08 |
≥4 | 355 (79.2) | 238 (84.7) | ||
| ||||
T-stage | T1c | 365 (81.5) | 197 (70.1) | 0.001 |
T2a | 83 (18.5) | 84 (29.9) | ||
| ||||
NeoHT | No | 310 (69.2) | 192 (68.3) | 0.81 |
Yes | 138 (30.8) | 89 (31.7) |
Median follow-up time, 77 months.
Median follow-up time, 76 months.
Used Fisher's exact test.